nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—Toothache—Metformin—metabolic syndrome X	0.00986	0.0478	CcSEcCtD
Cevimeline—Nail disorder—Metformin—metabolic syndrome X	0.00925	0.0449	CcSEcCtD
Cevimeline—Fungal infection—Metformin—metabolic syndrome X	0.00777	0.0377	CcSEcCtD
Cevimeline—Rigors—Metformin—metabolic syndrome X	0.00735	0.0356	CcSEcCtD
Cevimeline—Blood disorder—Metformin—metabolic syndrome X	0.00718	0.0348	CcSEcCtD
Cevimeline—Neuropathy—Metformin—metabolic syndrome X	0.00563	0.0273	CcSEcCtD
Cevimeline—Ear pain—Metformin—metabolic syndrome X	0.0051	0.0248	CcSEcCtD
Cevimeline—Injury—Metformin—metabolic syndrome X	0.00474	0.023	CcSEcCtD
Cevimeline—Renal impairment—Metformin—metabolic syndrome X	0.00458	0.0222	CcSEcCtD
Cevimeline—Hypoglycaemia—Metformin—metabolic syndrome X	0.00446	0.0216	CcSEcCtD
Cevimeline—Pain in extremity—Metformin—metabolic syndrome X	0.00436	0.0211	CcSEcCtD
Cevimeline—Migraine—Metformin—metabolic syndrome X	0.00429	0.0208	CcSEcCtD
Cevimeline—Dehydration—Metformin—metabolic syndrome X	0.00405	0.0196	CcSEcCtD
Cevimeline—Abdominal distension—Metformin—metabolic syndrome X	0.00379	0.0184	CcSEcCtD
Cevimeline—Sweating increased—Metformin—metabolic syndrome X	0.00367	0.0178	CcSEcCtD
Cevimeline—Angina pectoris—Metformin—metabolic syndrome X	0.00367	0.0178	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0035	0.017	CcSEcCtD
Cevimeline—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00329	0.016	CcSEcCtD
Cevimeline—Rhinitis—Metformin—metabolic syndrome X	0.00302	0.0146	CcSEcCtD
Cevimeline—Hypoaesthesia—Metformin—metabolic syndrome X	0.003	0.0145	CcSEcCtD
Cevimeline—Oedema peripheral—Metformin—metabolic syndrome X	0.00297	0.0144	CcSEcCtD
Cevimeline—Eye disorder—Metformin—metabolic syndrome X	0.00282	0.0137	CcSEcCtD
Cevimeline—Cardiac disorder—Metformin—metabolic syndrome X	0.0028	0.0136	CcSEcCtD
Cevimeline—Flushing—Metformin—metabolic syndrome X	0.0028	0.0136	CcSEcCtD
Cevimeline—Angiopathy—Metformin—metabolic syndrome X	0.00273	0.0133	CcSEcCtD
Cevimeline—Chills—Metformin—metabolic syndrome X	0.0027	0.0131	CcSEcCtD
Cevimeline—Malnutrition—Metformin—metabolic syndrome X	0.00262	0.0127	CcSEcCtD
Cevimeline—Flatulence—Metformin—metabolic syndrome X	0.00258	0.0125	CcSEcCtD
Cevimeline—Dysgeusia—Metformin—metabolic syndrome X	0.00257	0.0125	CcSEcCtD
Cevimeline—Muscle spasms—Metformin—metabolic syndrome X	0.00252	0.0122	CcSEcCtD
Cevimeline—Tremor—Metformin—metabolic syndrome X	0.00246	0.0119	CcSEcCtD
Cevimeline—Ill-defined disorder—Metformin—metabolic syndrome X	0.00243	0.0118	CcSEcCtD
Cevimeline—Malaise—Metformin—metabolic syndrome X	0.00237	0.0115	CcSEcCtD
Cevimeline—Syncope—Metformin—metabolic syndrome X	0.00235	0.0114	CcSEcCtD
Cevimeline—Palpitations—Metformin—metabolic syndrome X	0.00232	0.0112	CcSEcCtD
Cevimeline—Loss of consciousness—Metformin—metabolic syndrome X	0.00231	0.0112	CcSEcCtD
Cevimeline—Hypertension—Metformin—metabolic syndrome X	0.00226	0.011	CcSEcCtD
Cevimeline—Chest pain—Metformin—metabolic syndrome X	0.00223	0.0108	CcSEcCtD
Cevimeline—Myalgia—Metformin—metabolic syndrome X	0.00223	0.0108	CcSEcCtD
Cevimeline—Discomfort—Metformin—metabolic syndrome X	0.00221	0.0107	CcSEcCtD
Cevimeline—Oedema—Metformin—metabolic syndrome X	0.00214	0.0104	CcSEcCtD
Cevimeline—Infection—Metformin—metabolic syndrome X	0.00213	0.0103	CcSEcCtD
Cevimeline—Shock—Metformin—metabolic syndrome X	0.00211	0.0102	CcSEcCtD
Cevimeline—Nervous system disorder—Metformin—metabolic syndrome X	0.0021	0.0102	CcSEcCtD
Cevimeline—Thrombocytopenia—Metformin—metabolic syndrome X	0.0021	0.0102	CcSEcCtD
Cevimeline—Skin disorder—Metformin—metabolic syndrome X	0.00208	0.0101	CcSEcCtD
Cevimeline—Hyperhidrosis—Metformin—metabolic syndrome X	0.00207	0.01	CcSEcCtD
Cevimeline—Anorexia—Metformin—metabolic syndrome X	0.00204	0.00989	CcSEcCtD
Cevimeline—Hypotension—Metformin—metabolic syndrome X	0.002	0.0097	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00195	0.00946	CcSEcCtD
Cevimeline—Paraesthesia—Metformin—metabolic syndrome X	0.00192	0.00932	CcSEcCtD
Cevimeline—Dyspnoea—Metformin—metabolic syndrome X	0.00191	0.00925	CcSEcCtD
Cevimeline—Somnolence—Metformin—metabolic syndrome X	0.0019	0.00923	CcSEcCtD
Cevimeline—Dyspepsia—Metformin—metabolic syndrome X	0.00188	0.00914	CcSEcCtD
Cevimeline—Decreased appetite—Metformin—metabolic syndrome X	0.00186	0.00902	CcSEcCtD
Cevimeline—Fatigue—Metformin—metabolic syndrome X	0.00185	0.00895	CcSEcCtD
Cevimeline—Constipation—Metformin—metabolic syndrome X	0.00183	0.00888	CcSEcCtD
Cevimeline—Feeling abnormal—Metformin—metabolic syndrome X	0.00176	0.00855	CcSEcCtD
Cevimeline—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00175	0.00849	CcSEcCtD
Cevimeline—Urticaria—Metformin—metabolic syndrome X	0.0017	0.00825	CcSEcCtD
Cevimeline—Abdominal pain—Metformin—metabolic syndrome X	0.00169	0.00821	CcSEcCtD
Cevimeline—Asthenia—Metformin—metabolic syndrome X	0.00154	0.00745	CcSEcCtD
Cevimeline—Pruritus—Metformin—metabolic syndrome X	0.00151	0.00734	CcSEcCtD
Cevimeline—Diarrhoea—Metformin—metabolic syndrome X	0.00146	0.0071	CcSEcCtD
Cevimeline—Dizziness—Metformin—metabolic syndrome X	0.00142	0.00686	CcSEcCtD
Cevimeline—Vomiting—Metformin—metabolic syndrome X	0.00136	0.0066	CcSEcCtD
Cevimeline—Rash—Metformin—metabolic syndrome X	0.00135	0.00655	CcSEcCtD
Cevimeline—Dermatitis—Metformin—metabolic syndrome X	0.00135	0.00654	CcSEcCtD
Cevimeline—Headache—Metformin—metabolic syndrome X	0.00134	0.0065	CcSEcCtD
Cevimeline—Nausea—Metformin—metabolic syndrome X	0.00127	0.00617	CcSEcCtD
Cevimeline—CHRM1—Circadian rythm related genes—LEP—metabolic syndrome X	0.000566	0.000714	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GGT1—metabolic syndrome X	0.000563	0.000709	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—APOB—metabolic syndrome X	0.000549	0.000692	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.000548	0.00069	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.000546	0.000688	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PLA2G4A—metabolic syndrome X	0.000534	0.000673	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000531	0.000669	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000529	0.000666	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—LPL—metabolic syndrome X	0.000525	0.000661	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—GHRL—metabolic syndrome X	0.000503	0.000634	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—GHRL—metabolic syndrome X	0.000502	0.000632	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CD36—metabolic syndrome X	0.000498	0.000628	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—PPARG—metabolic syndrome X	0.000493	0.000622	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000485	0.000611	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000483	0.000609	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CNR1—metabolic syndrome X	0.000476	0.0006	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CNR1—metabolic syndrome X	0.000475	0.000598	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—FMO3—metabolic syndrome X	0.000469	0.00059	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PPARA—metabolic syndrome X	0.000463	0.000584	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—AGT—metabolic syndrome X	0.000449	0.000565	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—SERPINE1—metabolic syndrome X	0.000445	0.00056	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—APOE—metabolic syndrome X	0.00044	0.000554	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—APOA1—metabolic syndrome X	0.000435	0.000548	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MLXIPL—metabolic syndrome X	0.000418	0.000526	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—EPHX2—metabolic syndrome X	0.000418	0.000526	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000406	0.000511	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000404	0.000509	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—G6PC2—metabolic syndrome X	0.000393	0.000495	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000385	0.000485	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000384	0.000483	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PPARG—metabolic syndrome X	0.000383	0.000483	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—INS—metabolic syndrome X	0.000376	0.000473	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CCL5—metabolic syndrome X	0.000369	0.000465	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000368	0.000464	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CCL5—metabolic syndrome X	0.000368	0.000464	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00035	0.00044	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000349	0.000439	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—ALB—metabolic syndrome X	0.000344	0.000434	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000334	0.000421	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—FABP4—metabolic syndrome X	0.000334	0.000421	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000333	0.00042	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—NOS3—metabolic syndrome X	0.000329	0.000415	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HSD11B1—metabolic syndrome X	0.000317	0.000399	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—AGT—metabolic syndrome X	0.000309	0.000389	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—AGT—metabolic syndrome X	0.000308	0.000388	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PTGS2—metabolic syndrome X	0.000301	0.00038	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.0003	0.000378	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000299	0.000377	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000284	0.000358	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000283	0.000357	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—G6PD—metabolic syndrome X	0.000282	0.000355	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—FMO3—metabolic syndrome X	0.00028	0.000353	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HDAC3—metabolic syndrome X	0.000275	0.000347	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000272	0.000343	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000272	0.000342	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000269	0.000339	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—LPA—metabolic syndrome X	0.000269	0.000339	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GCKR—metabolic syndrome X	0.000269	0.000339	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000268	0.000338	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PLA2G6—metabolic syndrome X	0.000261	0.000328	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GHRL—metabolic syndrome X	0.000258	0.000325	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOA5—metabolic syndrome X	0.000258	0.000325	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GHRL—metabolic syndrome X	0.000257	0.000324	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CCL2—metabolic syndrome X	0.000254	0.000321	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CCL2—metabolic syndrome X	0.000254	0.000319	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	0.00025	0.000315	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	0.00025	0.000315	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CNR1—metabolic syndrome X	0.000245	0.000308	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CNR1—metabolic syndrome X	0.000244	0.000307	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TRIB3—metabolic syndrome X	0.00024	0.000302	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	0.000235	0.000296	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000231	0.000291	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HDAC3—metabolic syndrome X	0.00023	0.00029	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NAMPT—metabolic syndrome X	0.000215	0.000271	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—LIPC—metabolic syndrome X	0.000214	0.000269	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GCK—metabolic syndrome X	0.000214	0.000269	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOC3—metabolic syndrome X	0.000213	0.000268	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—IL6—metabolic syndrome X	0.000211	0.000266	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000209	0.000263	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000208	0.000262	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000207	0.00026	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CETP—metabolic syndrome X	0.000206	0.00026	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000206	0.000259	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RBP4—metabolic syndrome X	0.000201	0.000254	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000201	0.000254	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TRIB3—metabolic syndrome X	0.000201	0.000253	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RBP4—metabolic syndrome X	0.000201	0.000253	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.0002	0.000252	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.0002	0.000252	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—FABP4—metabolic syndrome X	0.0002	0.000252	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SCARB1—metabolic syndrome X	0.000198	0.000249	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SREBF1—metabolic syndrome X	0.000192	0.000242	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL5—metabolic syndrome X	0.00019	0.000239	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	0.000189	0.000238	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL5—metabolic syndrome X	0.000189	0.000238	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000189	0.000238	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000188	0.000237	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMGCR—metabolic syndrome X	0.000187	0.000235	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GOT2—metabolic syndrome X	0.000187	0.000235	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000183	0.000231	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOC3—metabolic syndrome X	0.000178	0.000225	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOC3—metabolic syndrome X	0.000178	0.000224	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000175	0.00022	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AGT—metabolic syndrome X	0.000174	0.000219	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—G6PD—metabolic syndrome X	0.000169	0.000213	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SLC2A4—metabolic syndrome X	0.000166	0.00021	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ABCA1—metabolic syndrome X	0.000166	0.00021	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	0.000165	0.000207	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000163	0.000206	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000163	0.000206	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GGT1—metabolic syndrome X	0.000161	0.000203	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GOT1—metabolic syndrome X	0.000161	0.000203	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GCKR—metabolic syndrome X	0.000161	0.000203	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LPA—metabolic syndrome X	0.000161	0.000203	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000161	0.000203	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2C—metabolic syndrome X	0.00016	0.000202	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AGT—metabolic syndrome X	0.000159	0.0002	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AGT—metabolic syndrome X	0.000158	0.000199	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	0.000156	0.000196	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CYBA—metabolic syndrome X	0.000156	0.000196	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CYBA—metabolic syndrome X	0.000155	0.000196	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA5—metabolic syndrome X	0.000154	0.000194	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000154	0.000193	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GHRL—metabolic syndrome X	0.000153	0.000192	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GHRL—metabolic syndrome X	0.000152	0.000192	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—AKT1—metabolic syndrome X	0.000151	0.000191	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CNR1—metabolic syndrome X	0.000144	0.000182	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CNR1—metabolic syndrome X	0.000144	0.000181	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	0.000143	0.000181	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOB—metabolic syndrome X	0.000137	0.000172	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PLA2G4A—metabolic syndrome X	0.000133	0.000167	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000131	0.000164	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000131	0.000164	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—LPL—metabolic syndrome X	0.000131	0.000164	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL2—metabolic syndrome X	0.00013	0.000164	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	0.000129	0.000162	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LIPC—metabolic syndrome X	0.000128	0.000161	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GCK—metabolic syndrome X	0.000128	0.000161	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOC3—metabolic syndrome X	0.000127	0.00016	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CD36—metabolic syndrome X	0.000124	0.000156	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.000124	0.000156	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CETP—metabolic syndrome X	0.000123	0.000155	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	0.000118	0.000149	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF2—metabolic syndrome X	0.000118	0.000149	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF2—metabolic syndrome X	0.000118	0.000148	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARA—metabolic syndrome X	0.000115	0.000145	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	0.000115	0.000144	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOB—metabolic syndrome X	0.000115	0.000144	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOB—metabolic syndrome X	0.000114	0.000144	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL5—metabolic syndrome X	0.000112	0.000141	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AGT—metabolic syndrome X	0.000112	0.000141	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL5—metabolic syndrome X	0.000112	0.000141	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	0.000112	0.000141	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GOT2—metabolic syndrome X	0.000112	0.000141	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000112	0.00014	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000111	0.00014	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—G6PD—metabolic syndrome X	0.00011	0.000139	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LPL—metabolic syndrome X	0.000109	0.000138	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOE—metabolic syndrome X	0.000109	0.000138	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LPL—metabolic syndrome X	0.000109	0.000137	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOA1—metabolic syndrome X	0.000108	0.000136	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	0.000108	0.000136	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPA—metabolic syndrome X	0.000105	0.000133	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCKR—metabolic syndrome X	0.000105	0.000133	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	0.000102	0.000128	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA5—metabolic syndrome X	0.000101	0.000127	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	9.94e-05	0.000125	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	9.94e-05	0.000125	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GOT1—metabolic syndrome X	9.63e-05	0.000121	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GGT1—metabolic syndrome X	9.63e-05	0.000121	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—metabolic syndrome X	9.53e-05	0.00012	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	9.38e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGT—metabolic syndrome X	9.37e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—INS—metabolic syndrome X	9.35e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AGT—metabolic syndrome X	9.34e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LEP—metabolic syndrome X	9.18e-05	0.000116	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOE—metabolic syndrome X	9.18e-05	0.000116	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOE—metabolic syndrome X	9.15e-05	0.000115	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LEP—metabolic syndrome X	9.15e-05	0.000115	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOA1—metabolic syndrome X	9.07e-05	0.000114	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOA1—metabolic syndrome X	9.04e-05	0.000114	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—metabolic syndrome X	8.57e-05	0.000108	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	8.41e-05	0.000106	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LIPC—metabolic syndrome X	8.36e-05	0.000105	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCK—metabolic syndrome X	8.36e-05	0.000105	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOC3—metabolic syndrome X	8.31e-05	0.000105	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—metabolic syndrome X	8.2e-05	0.000103	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	8.19e-05	0.000103	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOB—metabolic syndrome X	8.17e-05	0.000103	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	8.16e-05	0.000103	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CETP—metabolic syndrome X	8.07e-05	0.000102	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	7.95e-05	0.0001	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INS—metabolic syndrome X	7.84e-05	9.88e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INS—metabolic syndrome X	7.81e-05	9.84e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LPL—metabolic syndrome X	7.8e-05	9.83e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	7.72e-05	9.73e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	7.71e-05	9.72e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	7.69e-05	9.69e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	7.58e-05	9.55e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	7.56e-05	9.52e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	7.5e-05	9.45e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—metabolic syndrome X	7.5e-05	9.44e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CD36—metabolic syndrome X	7.41e-05	9.34e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GOT2—metabolic syndrome X	7.29e-05	9.19e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	7.29e-05	9.19e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.2e-05	9.07e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	7.18e-05	9.04e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARA—metabolic syndrome X	6.89e-05	8.68e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	6.87e-05	8.66e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	6.85e-05	8.63e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AGT—metabolic syndrome X	6.68e-05	8.41e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOE—metabolic syndrome X	6.54e-05	8.24e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	6.5e-05	8.19e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	6.5e-05	8.19e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA1—metabolic syndrome X	6.47e-05	8.15e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GOT1—metabolic syndrome X	6.3e-05	7.93e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GGT1—metabolic syndrome X	6.3e-05	7.93e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	5.89e-05	7.42e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	5.87e-05	7.4e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	5.8e-05	7.3e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	5.78e-05	7.28e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—metabolic syndrome X	5.7e-05	7.18e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INS—metabolic syndrome X	5.59e-05	7.04e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	5.35e-05	6.74e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOB—metabolic syndrome X	5.34e-05	6.73e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	5.33e-05	6.72e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	5.2e-05	6.55e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—metabolic syndrome X	5.12e-05	6.45e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPL—metabolic syndrome X	5.1e-05	6.43e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—metabolic syndrome X	4.9e-05	6.17e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CD36—metabolic syndrome X	4.85e-05	6.11e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	4.55e-05	5.73e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	4.53e-05	5.71e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARA—metabolic syndrome X	4.51e-05	5.68e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	4.48e-05	5.65e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AGT—metabolic syndrome X	4.36e-05	5.5e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOE—metabolic syndrome X	4.28e-05	5.39e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA1—metabolic syndrome X	4.23e-05	5.33e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKT1—metabolic syndrome X	3.77e-05	4.75e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—metabolic syndrome X	3.72e-05	4.69e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—INS—metabolic syndrome X	3.65e-05	4.6e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	3.43e-05	4.32e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	3.41e-05	4.3e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.35e-05	4.22e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.2e-05	4.04e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	3.16e-05	3.98e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	3.15e-05	3.97e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.93e-05	3.69e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.25e-05	2.84e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.47e-05	1.86e-05	CbGpPWpGaD
